{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T07:12:07Z","timestamp":1779261127966,"version":"3.51.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,19]]},"DOI":"10.7759\/cureus.109242","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T06:22:37Z","timestamp":1779258157000},"source":"Crossref","is-referenced-by-count":0,"title":["Multi-cavity Primary Effusion Lymphoma in a Cirrhotic Patient: A Rare Cause of Chylous Effusion"],"prefix":"10.7759","author":[{"given":"Trilok","family":"Chand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seema","family":"Rab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asiya","family":"Pathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiran","family":"Ravindran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14030722","article-title":"Primary effusion lymphoma: a clinicopathologic perspective","volume":"14","author":"Gathers DA","year":"2022","unstructured":"Gathers DA, Galloway E, Kelemen K, Rosenthal A, Gibson SE, Munoz J. Primary effusion lymphoma: a clinicopathologic perspective. Cancers (Basel). 2022, 14:10.3390\/cancers14030722","journal-title":"Cancers (Basel)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcu232","article-title":"Primary effusion lymphoma in the absence of HIV infection--clinical presentation and management","volume":"108","author":"Klepfish A","year":"2015","unstructured":"Klepfish A, Zuckermann B, Schattner A. Primary effusion lymphoma in the absence of HIV infection--clinical presentation and management. QJM. 2015, 108:481-8. 10.1093\/qjmed\/hcu232","journal-title":"QJM"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2000.02329.x","article-title":"Expression of MUM1\/IRF4 selectively clusters with primary effusion lymphoma among lymphomatous effusions: implications for disease histogenesis and pathogenesis","volume":"111","author":"Carbone A","year":"2000","unstructured":"Carbone A, Gloghini A, Cozzi MR, et al.. Expression of MUM1\/IRF4 selectively clusters with primary effusion lymphoma among lymphomatous effusions: implications for disease histogenesis and pathogenesis. Br J Haematol. 2000, 111:247-57. 10.1111\/j.1365-2141.2000.02329.x","journal-title":"Br J Haematol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V116.21.4136.4136","article-title":"Elevation of serum free light chains are common in lymphoma and associated with poor event-free and overall survival","volume":"116","author":"Maurer MJ","year":"2010","unstructured":"Maurer MJ, Cerhan JR, Katzmann JA, et al.. Elevation of serum free light chains are common in lymphoma and associated with poor event-free and overall survival. Blood. 2010, 116:4136. 10.1182\/blood.V116.21.4136.4136","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23839","article-title":"Elevated monoclonal and polyclonal serum immunoglobulin free light chain as prognostic factors in B- and T-cell non-Hodgkin lymphoma","volume":"89","author":"Witzig TE","year":"2014","unstructured":"Witzig TE, Maurer MJ, Habermann TM, et al.. Elevated monoclonal and polyclonal serum immunoglobulin free light chain as prognostic factors in B- and T-cell non-Hodgkin lymphoma. Am J Hematol. 2014, 89:1116-20. 10.1002\/ajh.23839","journal-title":"Am J Hematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.12-5-569","article-title":"Primary effusion lymphoma","volume":"12","author":"Chen YB","year":"2007","unstructured":"Chen YB, Rahemtullah A, Hochberg E. Primary effusion lymphoma. Oncologist. 2007, 12:569-76. 10.1634\/theoncologist.12-5-569","journal-title":"Oncologist"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08215-7","article-title":"Primary effusion lymphoma occurring in the setting of transplanted patients: a systematic review of a rare, life-threatening post-transplantation occurrence","volume":"21","author":"Zanelli M","year":"2021","unstructured":"Zanelli M, Sanguedolce F, Zizzo M, et al.. Primary effusion lymphoma occurring in the setting of transplanted patients: a systematic review of a rare, life-threatening post-transplantation occurrence. BMC Cancer. 2021, 21:468. 10.1186\/s12885-021-08215-7","journal-title":"BMC Cancer"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2013.1.103","article-title":"Human herpesvirus-8: Kaposi sarcoma, multicentric Castleman disease, and primary effusion lymphoma","volume":"2013","author":"Kaplan LD","year":"2013","unstructured":"Kaplan LD. Human herpesvirus-8: Kaposi sarcoma, multicentric Castleman disease, and primary effusion lymphoma. Hematology Am Soc Hematol Educ Program. 2013, 2013:103-8. 10.1182\/asheducation-2013.1.103","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2012.694075","article-title":"Prognosis in primary effusion lymphoma is associated with the number of body cavities involved","volume":"53","author":"Castillo JJ","year":"2012","unstructured":"Castillo JJ, Shum H, Lahijani M, Winer ES, Butera JN. Prognosis in primary effusion lymphoma is associated with the number of body cavities involved. Leuk Lymphoma. 2012, 53:2378-82. 10.3109\/10428194.2012.694075","journal-title":"Leuk Lymphoma"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1159\/000363223","article-title":"Primary effusion lymphoma in an elderly HIV-negative patient with hemodialysis: importance of evaluation for pleural effusion in patients receiving hemodialysis","volume":"4","author":"Sasaki Y","year":"2014","unstructured":"Sasaki Y, Isegawa T, Shimabukuro A, Yonaha T, Yonaha H. Primary effusion lymphoma in an elderly HIV-negative patient with hemodialysis: importance of evaluation for pleural effusion in patients receiving hemodialysis. Case Rep Nephrol Urol. 2014, 4:95-102. 10.1159\/000363223","journal-title":"Case Rep Nephrol Urol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e318267fabc","article-title":"KSHV\/HHV8-negative effusion-based lymphoma, a distinct entity associated with fluid overload states","volume":"37","author":"Alexanian S","year":"2013","unstructured":"Alexanian S, Said J, Lones M, Pullarkat ST. KSHV\/HHV8-negative effusion-based lymphoma, a distinct entity associated with fluid overload states. Am J Surg Pathol. 2013, 37:241-9. 10.1097\/PAS.0b013e318267fabc","journal-title":"Am J Surg Pathol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: lymphoid neoplasms","volume":"36","author":"Alaggio R","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, et al.. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: lymphoid neoplasms. Leukemia. 2022, 36:1720-48. 10.1038\/s41375-022-01620-2","journal-title":"Leukemia"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/crj.12122","article-title":"Uncommon aetiologies of chylothorax: superior vena cava syndrome and thoracic aortic aneurysm","volume":"9","author":"Gomes AO","year":"2015","unstructured":"Gomes AO, Ribeiro S, Neves J, Mendon\u00e7a T. Uncommon aetiologies of chylothorax: superior vena cava syndrome and thoracic aortic aneurysm. Clin Respir J. 2015, 9:185-8. 10.1111\/crj.12122","journal-title":"Clin Respir J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1183\/20734735.0163-2021","article-title":"Non-traumatic chylothorax: diagnostic and therapeutic strategies","volume":"18","author":"Ur Rehman K","year":"2022","unstructured":"Ur Rehman K, Sivakumar P. Non-traumatic chylothorax: diagnostic and therapeutic strategies. Breathe (Sheff). 2022, 18:210163. 10.1183\/20734735.0163-2021","journal-title":"Breathe (Sheff)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4065\/84.2.129","article-title":"Pleural fluid characteristics of chylothorax","volume":"84","author":"Maldonado F","year":"2009","unstructured":"Maldonado F, Hawkins FJ, Daniels CE, Doerr CH, Decker PA, Ryu JH. Pleural fluid characteristics of chylothorax. Mayo Clin Proc. 2009, 84:129-33. 10.4065\/84.2.129","journal-title":"Mayo Clin Proc"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.939098","article-title":"Chylothorax: atangled road to definitive diagnosis of non-Hodgkin lymphoma","volume":"24","author":"Kr\u016bmi\u0146a A","year":"2023","unstructured":"Kr\u016bmi\u0146a A, Auzi\u0146a D, Legzdi\u0146a A, Lejniece S. Chylothorax: atangled road to definitive diagnosis of non-Hodgkin lymphoma. Am J Case Rep. 2023, 24:e939098. 10.12659\/AJCR.939098","journal-title":"Am J Case Rep"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-018-0991-3","article-title":"Experiences in the treatment of refractory chylothorax associated with lymphoproliferative disorders","volume":"14","author":"Pospiskova J","year":"2019","unstructured":"Pospiskova J, Smolej L, Belada D, et al.. Experiences in the treatment of refractory chylothorax associated with lymphoproliferative disorders. Orphanet J Rare Dis. 2019, 14:9. 10.1186\/s13023-018-0991-3","journal-title":"Orphanet J Rare Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijscr.2022.107827","article-title":"Indonesian female with bilateral chylothorax and mediastinal non-Hodgkin lymphoma: a case report","volume":"102","author":"Wijaya SY","year":"2023","unstructured":"Wijaya SY, Koesoemoprodjo W. Indonesian female with bilateral chylothorax and mediastinal non-Hodgkin lymphoma: a case report. Int J Surg Case Rep. 2023, 102:107827. 10.1016\/j.ijscr.2022.107827","journal-title":"Int J Surg Case Rep"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S167392","article-title":"Primary effusion lymphoma: current perspectives","volume":"11","author":"Narkhede M","year":"2018","unstructured":"Narkhede M, Arora S, Ujjani C. Primary effusion lymphoma: current perspectives. Onco Targets Ther. 2018, 11:3747-59. 10.2147\/OTT.S167392","journal-title":"Onco Targets Ther"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.5582\/irdr.2014.01010","article-title":"Current status of treatment for primary effusion lymphoma","volume":"3","author":"Okada S","year":"2014","unstructured":"Okada S, Goto H, Yotsumoto M. Current status of treatment for primary effusion lymphoma. Intractable Rare Dis Res. 2014, 3:65-74. 10.5582\/irdr.2014.01010","journal-title":"Intractable Rare Dis Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/467075-multi-cavity-primary-effusion-lymphoma-in-a-cirrhotic-patient-a-rare-cause-of-chylous-effusion","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T06:22:38Z","timestamp":1779258158000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/467075-multi-cavity-primary-effusion-lymphoma-in-a-cirrhotic-patient-a-rare-cause-of-chylous-effusion"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.109242","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,19]]}}}